A Case of Recurrence of Fibrolamellar Hepatocellular Carcinoma After 18 Years Underscores the Need for Extended Patient Surveillance

Cureus. 2024 Jul 9;16(7):e64156. doi: 10.7759/cureus.64156. eCollection 2024 Jul.

Abstract

Fibrolamellar hepatocellular carcinoma (FLC) is a rare form of primary liver cancer that predominantly affects adolescents and young adults with no history of cirrhosis. Surgical resection is a potentially curative treatment option, but the optimal duration of surveillance after a potentially curative surgical resection is not known. Here, we present a case of a patient with FLC who developed a recurrence of FLC nearly two decades after resection of the primary tumor. Although the optimal duration of imaging surveillance for FLC is not known, this case report provides initial evidence that long-term surveillance in patients with FLC who have received curative intent surgery is warranted.

Keywords: cancer surveillance; fibrolamellar; fibrolamellar hepatocellular carcinoma; hepatocellular carcinoma (hcc); liver cancer.

Publication types

  • Case Reports

Grants and funding

Author MY reports honoraria from Genentech, Exelixis, AstraZeneca, Replimune, Hepion, and Lantheus